ITERUM THERAPEUTICS PLC (ITRM)
IE000TTOOBX0 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 510K | 870K 70.59% | 40K -95.40% | -100.00% | 6.424M | 16.759M 160.88% | 42.912M 156.05% | 92.854M 116.38% | 151.94M 63.63% | 340.05M 123.81% | 448.55M 31.91% | |||||
| EBITDA YoY % growth | -29.39M -119.99% | -76.42M -160.02% | -101.87M -33.30% | -34.986M 68.63% | N/A 29.79% | N/A -27.36% | N/A -59.97% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -29.46M -120.51% | -76.56M -159.88% | -102.02M -33.25% | -35.463M 68.52% | -24.692M 23.60% | -41.231M -23.80% | -48.998M -56.25% | -20.606M 56.59% | -19.108M 7.27% | -15.467M 19.05% | -3.248M 79.00% | 29.081M 995.30% | 72.236M 148.40% | 120.2M 66.40% | 169.48M 41.00% | |
| Operating Margin | -5,776.47% | -8,800.00% | -255,050.00% | N/A | N/A | N/A | N/A | N/A | -297.44% | -92.29% | -7.57% | 31.32% | 47.54% | 35.35% | 37.78% | |
| EPS YoY % growth | N/A | N/A | -106.65 26.89% | -37.28 63.85% | -8.72 70.04% | -3.06 80.26% | -3.01 -32.20% | -1.19 60.41% | -0.74 37.61% | -0.59 21.23% | -0.36 39.13% | 0.22 162.86% | 1.17 422.73% | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.19 79.38% | -0.18 61.20% | -0.18 40.50% | -0.18 40.50% | -0.15 23.68% |
| Revenue Q2Q % growth | 1.368M | 1.428M | 1.547M | 2.081M | |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -5.374M 52.98% | -4.822M 21.77% | -4.916M -23.64% | -5.003M -2.37% | -4.368M 18.73% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.30 | -0.20 | -0.10 | -47.06% |
| Q2 2024 Q2Q % growth | -0.30 68.42% | -0.46 | 0.16 | 34.64% |
| Q1 2024 Q2Q % growth | -0.46 62.42% | -0.74 | 0.28 | 37.80% |
| Q4 2023 Q2Q % growth | -0.94 -129.27% | -0.95 | 0.01 | 1.44% |
| Q3 2023 Q2Q % growth | -0.30 69.07% | -0.93 | 0.63 | 67.68% |
| Q2 2023 Q2Q % growth | -0.95 -58.33% | -1.22 | 0.27 | 22.39% |
| Q1 2023 Q2Q % growth | -308.00% | -1.22 | % | |
| Q4 2022 Q2Q % growth | -0.41 -36.67% | -1.22 | 0.81 | 66.50% |
| Q3 2022 Q2Q % growth | -0.97 -423.33% | -1.07 | 0.10 | 9.43% |
| Q2 2022 Q2Q % growth | -0.60 -200.00% | -1.07 | 0.47 | 43.98% |
| Q1 2022 Q2Q % growth | -0.30 97.53% | -0.77 | 0.47 | 60.78% |
| Q4 2021 Q2Q % growth | -0.30 92.59% | -0.61 | 0.31 | 50.98% |
| Q3 2021 Q2Q % growth | 0.30 103.33% | 1.84 | -1.54 | -83.66% |
| Q2 2021 Q2Q % growth | 0.60 105.00% | -0.99 | 1.59 | 160.33% |
| Q1 2021 Q2Q % growth | -12.15 10.00% | -1.07 | -11.08 | -1,034.45% |
| Q4 2020 Q2Q % growth | -4.05 83.02% | -2.96 | -1.09 | -36.92% |
| Q3 2020 Q2Q % growth | -9.00 72.09% | -7.85 | -1.15 | -14.59% |
| Q2 2020 Q2Q % growth | -12.00 58.55% | -12.39 | 0.39 | 3.17% |
| Q1 2020 Q2Q % growth | -13.50 37.50% | -20.46 | 6.96 | 34.03% |
| Q4 2019 Q2Q % growth | -23.85 | -26.05 | 2.20 | 8.44% |
| Q3 2019 Q2Q % growth | -32.25 | -25.21 | -7.04 | -27.94% |
| Q2 2019 Q2Q % growth | -28.95 | -23.41 | -5.54 | -23.67% |
| Q1 2019 Q2Q % growth | -21.60 | -20.60 | -1.00 | -4.83% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2020 Q2Q % growth | -100.00% | % | ||
| Q3 2019 Q2Q % growth | 71.4K | -71.4K | -100.00% | |
| Q2 2019 Q2Q % growth | 76.5K | -76.5K | -100.00% | |
| Q1 2019 Q2Q % growth | 40K | 153K | -113K | -73.86% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 48.65% | -11.43% | -5.41% |
| Revenue | N/A | N/A | N/A | N/A |